Adhere to the highest standards of transparency by ensuring that the scientific data generated by its research is made publicly available.
Require publicly funded scientific data generated by the institute to be made publicly available.
Occurrences
Evidence
legacy_unverified · Source version not recorded · locator unknown
GovInfo bill text shows H.R. 7854 was introduced by Rep. Rashida Tlaib on March 5, 2026 and referred to the House Energy and Commerce and Judiciary Committees. The introduced text would require the Institute to share preclinical and clinical trial data, make all data developed in research and development publicly available online, and require entities funded by the Institute to share scientific data.
legacy_unverified · Source version not recorded · locator unknown
Rep. Tlaib's official release says she introduced the Medicines for the People Act to establish a National Institute for Biomedical Research and Development, and lists as a function that the Institute would adhere to transparency standards by ensuring scientific data generated by its research is made publicly available.
Assessments
Tlaib introduced H.R. 7854, the Medicines for the People Act, in the 119th Congress on March 5, 2026, and the bill text contains the promised public-availability requirements for institute-funded scientific data. However, the official record shows introduction and committee referral only, with no enactment or implemented requirement as of August 16, 2026. Because the bill remains pending in her current federal term rather than definitively failed, the promise is not yet delivered but she merits an effort badge.